Imaging Pioneer Canfield Scientific Launches Commercial Version of the VECTRA® WB360 Whole Body Imaging Solution

PARSIPPANY, N.J., March 8, 2017 /PRNewswire/ -- Continuing a 30 year tradition of breakthrough skin imaging innovations, Canfield Scientific completed the commercial launch of the whole body, 3D imaging system called the VECTRA® WB360, at the 75^th Annual Meeting of the American Academy of Dermatology in Orlando, Florida.  Designed primarily for dermatology, this state-of-the-art system simultaneously captures the entire exposed skin surface using 46 stereo vision pods and produces a single high-resolution 3D image.  After undergoing rigorous use at four (4) skin cancer centers over the last three years, the VECTRA WB360 has been proven the most advanced solution for skin cancer screenings, providing potentially life-saving information to clinicians.  Other applications of the VECTRA WB360 include reviewing skin conditions such as psoriasis, vitiligo, CTCL, neurofibromatosis and for burn management, lymphedema management, and plastic and reconstructive surgery, since accurate body surface area measurements are only possible with 3D and 360 degree imaging. 

The VECTRA WB360 utilizes a combination of polarized and non-polarized lighting and the Canfield-designed custom lighting modules use proprietary xenon flash technology tuned for capturing skin surface images. The system is scalable and offered in two configurations.  The VECTRA WB180 creates a front-of-the-body image and then a back-of-the-body image, providing full body visualization for clinical review.   With multiple patents pending, the innovative design enables unprecedented simplicity and standardization of patient photography, eliminates the need for skilled medical photographers, and delivers tremendous patient benefit by reducing the photographic time to take both polarized and non-polarized captures to less than a second.

The advanced DermaGraphix® Body Mapping Solution is designed to maximize the unique, high resolution 3D body images of the VECTRA WB360.  The powerful and elegantly designed dashboard provides a complete view of the patient photographic history at a glance.  Wireless lesion tagging with the VEOS® DS3 dermatoscope provides unmatched user convenience and links all images associated with a lesion to the 3D body map for efficient exams and follow-ups.  The DermaGraphix Visualizer™ takes all visible segmented lesions and displays them with a powerful interface that reveals the "ugly duckling" lesion.  The DermaGraphix Tracker™ identifies new and changed lesions and will be available in the second half of 2017.  The DermaGraphix Viewer, provided on a secure drive, empowers individuals to monitor their own lesions between visits, increasing the chances that they will identify suspect lesions in their early, and most treatable stages.

"We believe the VECTRA WB360 will revolutionize how physicians monitor high-risk patients," said founder and President Doug Canfield. "Our technology can help improve and even save lives."  The VECTRA WB360 is available worldwide directly from Canfield Scientific.  For detailed information and pricing on all of the applications and capabilities of the system please visit www.canfieldsci.com.

About Canfield Scientific: For over 30 years, Canfield Scientific has been the worldwide leader in the design and development of imaging systems, services and products for the medical, pharmaceutical, cosmetic and skin care industries. Early users of VECTRA WB360 include Skin Cancer research leaders, Memorial Sloan Kettering Cancer Center in New York City and Princess Alexandra Hospital in Brisbane, Australia. For more information contact Dennis O'Neal at 800-815-4330.

Contact: Dennis O'Neal - Canfield Scientific, 800-815-4330

SOURCE Canfield Imaging Systems